| J9271 | Injection, pembrolizumab, 1 mg | 11,000 | $40 | $473K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 7,560 | $40 | $287.3K |
| J1930 | Injection, lanreotide, 1 mg | 2,760 | $40 | $107.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 260 | $140 | $36.7K |
| J0897 | Injection, denosumab, 1 mg | 1,800 | $20 | $32.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $100 | $21.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $100 | $20.7K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 70 | $160 | $10.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $120 | $7.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 120 | $60 | $6.7K |